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Introduction
            Supraventricular tachycardias are quite common in clinical practice. Medical treatment 
of supraventricular tachycardia often involves regular intake of drugs for several years. Problems 
of drug therapy include poor efficacy and bothersome side effects including proarrhythmia. This 
has lead to the development of non-pharmacological therapies. Arrhythmia surgery initially 
demonstrated that many types of supraventricular arrhythmias could be cured. However during 
the past decade arrhythmia surgery has been largely replaced by catheter ablation. Catheter 
ablation can be defined as the use of an electrode catheter to destroy small areas of myocardial 
tissue or conduction system, or both, that are critical to the initiation or maintenance of cardiac 
arrhythmias. Arrhythmias most likely to be amenable to cure with catheter ablation are those 
which have a focal origin or involve a narrow, anatomically defined isthmus.1 This review aims 
to provide an update on the technique and results associated that can be achieved with catheter 
ablation of supraventricular tachycardias. 
Classification of Supraventricular Tachyarrhythmias                                       
            Supraventricular tachyarrhythmias have been classified into regular and irregular (atrial 
fibrillation).2  Atrial fibrillation is less amenable to cure with catheter ablation than are the 
regular forms of supraventricular tachyarrhythmias such as atrioventricular nodal reentrant 
tachycardia   (AVNRT)   and   atrio-ventricular   reciprocating   tachycardia.(AVRT).   Non-
pharmacological   treatment   of   atrial   fibrillation   has   been   reviewed   recently.3  Regular 
supraventricular tachycardias (SVT) can be cured by catheter ablation with high success rates 
(95-99%) and low complication rates (< 1%)2. Regular SVTs can be subdivided into:  
1. Atrioventricular re-entry tachycardias (AVRT), using the ventricle as part of the circuit; these 
tachycardias are dependent on the presence of an accessory atrioventricular (AV) pathway. 
2. Atrioventricular nodal re-entry tachycardia (AVNRT), where the re-entry circuit is within the 
AV   node   and   the   ventricle   plays   no   part   in   maintaining   the   arrhythmia.  
3. Atrial tachycardia, where the re-entry circuit does not involve any part of the AV junction e.g. 
atrial   flutter,   ectopic  atrial  tachycardia.                                                                  
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Technique   of   Ablation                                                                
             Catheter ablations are performed in cardiac electrophysiology laboratories specially 
equipped with recorders, programmed stimulators and ablators. Ever since 1989, radiofrequency 
current has been used for ablation, while earlier attempts were with direct current. The procedure 
is typically performed using conscious sedation. Two to five multipolar electrode catheters are 
inserted percutaneously under local anaesthesia into a femoral, brachial, subclavian, or internal 
jugular veins and positioned in the heart under fluoroscopic guidance. Each electrode catheter 
has four or more electrodes. The most distal electrode pair is usually used for pacing and the 
delivery of critically timed extra stimuli, while all of the electrodes are used to record 
electrograms from localised regions within the heart. Up to 50 W of radiofrequency energy is 
delivered for 30-60 seconds as a continuous, unmodulated, sinusoidal waveform with a 
frequency of approximately 500,000 Hz, between the 4 mm tip of a deflectable ablation catheter 
and a ground plate positioned on the patient's back or chest. The temperature of the ablation 
electrode can be monitored and the power output automatically adjusted to achieve a targeted 
electrode temperature of between 60-70°C. Knowledge of the electrode temperature at a 
particular   ablation  site  is   useful  in  determining  whether   an  unsuccessful  application  of 
radiofrequency energy failed because of inaccurate mapping or inadequate heating.4  If the 
failure was as a result of inadequate heating, additional applications of energy at the same site 
with improved catheter stability may succeed. Automatic adjustment of power output using 
closed  loop  temperature  control  has   been  shown  to  reduce  the  incidence  of   coagulum 
development. This reduces the number of times the catheter has to be withdrawn from the body 
to have a coagulum removed from the electrode tip. Thermal injury is the main mechanism of 
tissue destruction during radiofrequency catheter ablation. Elevation of tissue temperature results 
in desiccation and the denaturation of proteins, and coagulation of tissue and blood. Irreversible 
tissue injury occurs at temperatures above 50°C. When temperature reaches 100°C, plasma 
proteins denature to form a coagulum. The coagulum causes a sharp rise in the impedance and a 
corresponding fall in the current density, thereby limiting further lesion growth. Methods for 
improved   cooling   of   the   electrode   have   been   developed   to   allow   delivery   of   higher 
radiofrequency power without the formation of coagulum. These include the use of larger (8 
mm) electrodes, which receive greater convective cooling by the blood, and saline irrigated 
electrode tips, in which the electrode is actively cooled. Biplane fluroscopic imaging gives a 
three dimensional orientation of catheter position, enabling better localization. Non fluroscopic 
imaging systems using magnetic fields and ultrasound are being developed. These modalities 
avoid the inherent risk of radiation exposure to the patient and the treating physician.
Ablation of atrioventricular re-entry tachycardias (AVRT)                                  
             AVRT utilizes accessory pathways which are anomalous extra nodal connections 
between the epicardial surface of the atrium and ventricle along the atrioventricular groove. 
Accessory pathways can be classified based on their location along the mitral or tricuspid 
annulus, type of conduction (decremental or non-decremental), and whether they are capable of 
antegrade conduction, retrograde conduction, or both. Accessory pathways which are capable 
only of retrograde conduction are concealed while those capable of antegrade conduction are 
manifest, demonstrating pre-excitation on a standard ECG. AVRT is the most common 
arrhythmia in patients with a manifest accessory pathway, occurring in 75% of cases.       
             An electrophysiological study is performed to localise the accessory pathway and 
determine its conduction characteristics prior to ablation. Accurate localisation of an accessory 
pathway is critical to the success of catheter ablation procedures. Preliminary localisation of the 
accessory pathway can be determined based on the delta wave and QRS morphology on the 
surface ECG in patients with manifest pre-excitation. Mapping of concealed accessory pathways 
and more accurate localisation of manifest accessory pathways require analysis of the retrograde 
atrial activation sequence and/or antegrade ventricular activation sequence. Right sided and 
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posteroseptal accessory pathways are typically localised and ablated using a steerable electrode 
catheter with a 4 mm distal electrode positioned along the tricuspid annulus or in the coronary 
sinus os from the inferior vena cava. The location of left sided accessory pathways can be 
determined using a multipolar electrode catheter positioned in the coronary sinus, which runs 
parallel to the left atrioventricular groove or with a steerable catheter positioned in the left 
atrium or ventricle. Once localised to a region of the heart, precise mapping and ablation is 
performed using a steerable 4 mm tipped electrode catheter positioned along the mitral annulus 
using either the transeptal or retrograde aortic approach. These two approaches for ablation of 
left sided accessory pathways are associated with a similar rate of success and incidence of 
complications.5  The decision over which approach to employ is usually based on physician 
preference, although the transeptal approach may be preferable in the elderly and in young 
children. In rare instances, left sided accessory pathways can only be ablated via the coronary 
sinus.  
             Appropriate sites for radiofrequency energy delivery during ablation of manifest 
accessory pathways are characterised by early ventricular activation, the presence of an 
accessory pathway potential, and stability of the local electrogram6. Appropriate sites for energy 
delivery in patients with retrograde conduction accessory pathways mapped during ventricular 
pacing or orthodromic AVRT are characterised by continuous electrical activity, the presence of 
accessory pathway potential, and electrogram stability. Once an appropriate target site is 
identified, radiofrequency energy is delivered for 30-60 seconds with a target electrode 
temperature of 60-70°C. At successful ablation sites, interruption of conduction through the 
accessory pathway usually occurs within 10 seconds, and often within two seconds of the onset 
of   radiofrequency   energy   delivery.                                                          
            Efficacy of catheter ablation of accessory pathways varies from 89-99%.7-9 The success 
rate is highest for left free wall accessory pathways and lowest for posteroseptal and right free 
wall accessory pathways. Recurrence of conduction occurs in approximately 7%.7-9  Recurrence 
is more common following ablation of posteroseptal and right free wall pathways. Accessory 
pathways which recur can usually be successfully reablated. Complications associated with 
catheter ablation may result from vascular access (haematomas, deep venous thrombosis, 
perforation of the aorta, arteriovenous fistula, pneumothorax), catheter manipulation (valvar 
damage, microemboli, perforation of the coronary sinus or myocardial wall, coronary dissection 
and/or thrombosis), or delivery of radiofrequency energy (atrioventricular block, myocardial 
perforation, coronary artery spasm or occlusion, transient ischaemic attacks or cerebrovascular 
accidents). Complete heart block occurs in about 1% of patients, most commonly after ablation 
of septal and posteroseptal accessory pathways. The overall incidence of complications varies 
between 1-4%. Procedure related death is estimated to be less than 0.2%.9
Ablation of Atrioventricular Nodal Re-entrant tachycardia                                           
            Atrioventricular nodal re-entrant tachycardia (AVNRT) occurs in patients with dual AV 
nodal physiology. They have two functionally distinct pathways known as the slow and fast 
pathway. The slow pathway has a shorter refractory period. During the common form of 
AVNRT, an atrial premature beat travels down the slow pathway and gets conducted back by the 
fast pathway to depolarise the atrium. In the uncommon variety, the reverse pattern occurs. The 
fast pathway is located anteriorly along the septal portion of the tricuspid annulus, near the 
compact atrioventricular node, whereas the atrial insertion of the slow pathway is located more 
posteriorly along the tricuspid annulus, closer to the coronary sinus ostium.                    
            AVNRT can be cured by ablating either the fast pathway or the slow pathway. However, 
it has clearly been shown that catheter ablation of the slow pathway using a "posterior approach" 
is associated with greater safety and efficacy. For this reason, the "anterior approach" is merely 
of historical interest. Fast pathway ablation is by an "anterior" approach. Catheter ablation is 
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performed by locating an electrogram with a large His potential and then withdrawing the 
ablation catheter into the right atrium until the atrial signal is at least twice that of the ventricular 
signal (A:V ratio > 2) with a His potential no larger than 50 µV. Radiofrequency energy is then 
applied during sinus rhythm for 30-60 seconds while watching for prolongation in the PR 
interval. Energy delivery is immediately terminated if atrioventricular block occurs. Successful 
ablation of AVNRT is characterised by lengthening of the PR interval and the inability to induce 
the tachycardia. There is elimination or pronounced attenuation of retrograde conduction during 
ventricular pacing. The atrioventricular block cycle length and the atrioventricular node effective 
refractory period are not usually altered during ablation by the anterior approach. Anterior 
approach is successful in about 90% of cases. Inadvertent atrioventricular block occurs in 
approximately 7% of patients. Recurrence rate is about 9%.1                                          
            Slow pathway ablation is by the "posterior" approach. The ablation catheter is directed 
into the right ventricle low near the posterior septum and is then withdrawn until an electrogram 
is recorded with a small atrial electrogram and a large ventricular electrogram (A:V ratio < 0.5). 
Specific ablation sites along the posterior portion of the tricuspid annulus can be selected based 
either on the appearance of the local atrial electrogram or based strictly on anatomic factors. 
While using the electrogram guided approach, fractionated atrial electrograms with a late "slow 
potential" are targeted. In the anatomic approach, the initial applications are delivered at the 
level of the coronary sinus ostium and subsequent applications at more superior sites. Junctional 
beats occurring during the application of radiofrequency energy are a marker for successful 
ablation. Successful ablation is characterised by an increase in the atrioventricular block cycle 
length and in the atrioventricular node effective refractory period and elimination of inducible 
AVNRT. The posterior approach for ablation of AVNRT is effective in greater than 95-97% of 
patients.9-11  Atrioventricular block occurs in 0.5-1% and is the most common complication. 
Recurrence following successful ablation using the posterior approach is approximately 3%. 
Posterior approach is the preferred approach to ablation of AVNRT due to the higher efficacy, 
lower incidence of atrioventricular block and arrhythmia recurrence, and the greater likelihood 
of maintaining a normal PR interval during sinus rhythm.                                        
Atrial   Tachycardias                                                                          
            Catheter ablation of sustained regular atrial tachycardias can also be performed with high 
safety and efficacy. Focal atrial tachycardia, whether reentrant, automatic, or triggered can be 
ablated with success rates greater than 90%. The site for ablation is generally chosen based on 
early activation. Typical atrial flutter is also amenable to cure with catheter ablation. This 
macroreentrant arrhythmias is localized to the right atrium. Atrial flutter can be cured by 
creating a continuous, transmural, linear lesion between the tricuspid annulus and the inferior 
vena cava. This procedure is generally referred to as an "isthmus" ablation. Catheter ablation of 
atrial flutter can be performed with an efficacy greater than 90% and a < 5% risk of recurrence 
of atrial flutter. Non-isthmus dependant atrial flutter can also be treated with catheter ablation. 
These regular atrial tachycardias, with rates between 250 and 350 bpm often involve scars 
created during prior cardiac surgery. The procedure can be accomplished by defining a critical 
region of conduction which is necessary for maintenance of the arrhythmia. The creation of a 
linear lesion in this region can result in cure of the tachycardia. Catheter ablation of non-isthmus 
dependant atrial flutter can be accomplished with an efficacy of greater than 80% and a < 5% 
risk   of   major   complications.                                                                    
Conclusion
            Because of the remarkable safety and efficacy of catheter ablation, it is now considered 
as first line therapy for most types of supraventricular arrhythmias. These include AVNRT, 
AVRT, atrial tachycardia, and atrial flutter. It is anticipated that the dream of curing atrial 
fibrillation with ablation techniques will also be realized sometime during the next five years. 
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